A theranostic small interfering RNA nanoprobe protects pancreatic islet grafts from adoptively transferred immune rejection

Diabetes

Volumn 61, Issue 12, 2012, Pages 3247-3254

  Wang, Ping ^a   Yigit, Mehmet V ^a   Ran, Chongzhao ^a   Ross, Alana ^a   Wei, Lingling ^a   Dai, Guangping ^a   Medarova, Zdravka ^a   Moore, Anna ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; SMALL INTERFERING RNA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLUORESCENCE MICROSCOPY; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NANOPROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; MICE, SCID; RNA, SMALL INTERFERING;

EID: 84870316956     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0441     Document Type: Article

References (46)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75 (Pubitemid 28304880)
3. Troppmann C. Complications after pancreas transplantation. Curr Opin Organ Transplant 2010;15:112-118
4. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-1330 (Pubitemid 44465460)
5. Alejandro R, Barton FB, Hering BJ, Wease S; Collaborative Islet Transplant Registry Investigators. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008;86:1783-1788
6. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005;77:587-597 (Pubitemid 40628740)
7. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 2004;4:259-268 (Pubitemid 38478661)
8. Worcester Human Islet Transplantation Group. Autoimmunity after isletcell allotransplantation. N Engl J Med 2006;355:1397-1399
9. Niclauss N, Bosco D, Morel P, Giovannoni L, Berney T, Parnaud G. Rapamycin impairs proliferation of transplanted islet b cells. Transplantation 2011;91:714-722
10. Zahr E, Molano RD, Pileggi A, et al. Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation 2007;84:1576-1583
11. Bouwman LH, Ling Z, Duinkerken G, Pipeleers DG, Roep BO. HLA incompatibility and immunogenicity of human pancreatic islet preparations cocultured with blood cells of healthy donors. Hum Immunol 2005;66:494-500 (Pubitemid 40797547)
12. Rickels MR, Kamoun M, Kearns J, Markmann JF, Naji A. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab 2007;92:2410-2414 (Pubitemid 47037334)
13. Rickels MR, Kearns J, Markmann E, et al. HLA sensitization in islet transplantation. Clin Transpl 2006:413-420
14. Ekser B, Ezzelarab M, Hara H, et al. Clinical xenotransplantation: the next medical revolution? Lancet 2012;379:672-683
15. Lin CC, Ezzelarab M, Shapiro R, et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 2010;10:1556-1568
16. Mirenda V, Golshayan D, Read J, et al. Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. Diabetes 2005;54:1048-1055 (Pubitemid 40446318)
17. Zhan Y, Brady JL, Sutherland RM, Lew AM. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing. J Immunol 2001;167:6279-6285 (Pubitemid 33081558)
18. Yi S, Feng X, Hawthorne W, Patel A, Walters S, O'Connell PJ. CD8+ T cells are capable of rejecting pancreatic islet xenografts. Transplantation 2000;70:896-906
19. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811 (Pubitemid 28099681)
20. Figueiredo C, Seltsam A, Blasczyk R. Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery. J Mol Med (Berl) 2006;84:425-437 (Pubitemid 43673617)
21. Haga K, Lemp NA, Logg CR, et al. Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: averting cytotoxicity by alloreactive T lymphocytes. Transplant Proc 2006;38:3184-3188 (Pubitemid 44908534)
22. Hacke K, Falahati R, Flebbe-Rehwaldt L, Kasahara N, Gaensler KM. Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantation. Immunol Res 2009;44:112-126
23. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003;80:148-158 (Pubitemid 37272241)
24. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-256 (Pubitemid 36077924)
25. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 2006;12:144-148 (Pubitemid 43050090)
26. Evgenov NV, Medarova Z, Pratt J, et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 2006;55:2419-2428 (Pubitemid 44872728)
27. Wang P, Yigit MV, Medarova Z, et al. Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantation. Diabetes 2011;60:565-571
28. Thomas HE, Parker JL, Schreiber RD, Kay TW. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest 1998;102:1249-1257 (Pubitemid 28436285)
29. Toso C, Pawlick R, Lacotte S, et al. Detecting rejection after mouse islet transplantation utilizing islet protein-stimulated ELISPOT. Cell Transplant 2011;20:955-962
30. Deeds MC, Anderson JM, Armstrong AS, et al. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim 2011;45:131-140
31. Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A. In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc 2006;1:429-435
32. Evgenov NV, Pratt J, Pantazopoulos P, Moore A. Effects of glucose toxicity and islet purity on in vivo magnetic resonance imaging of transplanted pancreatic islets. Transplantation 2008;85:1091-1098 (Pubitemid 351590185)
33. Ramirez-Victorino F, Beilke JN, Gill RG. Both innate and adaptive major histocompatibility complex class I-dependent immunity impair long-term islet xenograft survival. Transplant Proc 2008;40:557-558 (Pubitemid 351406450)
34. Markmann JF, Bassiri H, Desai NM, et al. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation 1992;54:1085-1089 (Pubitemid 23005549)
35. Duprat E, Lefranc MP, Gascuel O. A simple method to predict proteinbinding from aligned sequences-application to MHC superfamily and beta2-microglobulin. Bioinformatics 2006;22:453-459 (Pubitemid 43231420)
36. Hill DM, Kasliwal T, Schwarz E, et al. A dominant negative mutant beta 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain. J Biol Chem 2003;278:5630-5638 (Pubitemid 36800805)
37. Alexander AM, Crawford M, Bertera S, et al. Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002;51:356-365 (Pubitemid 34764790)
38. Christianson SW, Greiner DL, Hesselton RA, et al. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 1997;158:3578-3586 (Pubitemid 127488709)
39. Triponez F, Oberholzer J, Morel P, et al. Xenogeneic islet re-transplantation in mice triggers an accelerated, species-specific rejection. Immunology 2000;101:548-554 (Pubitemid 32001470)
40. Young HY, Zucker P, Flavell RA, Jevnikar AM, Singh B. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation. Transplantation 2004;78:509-515 (Pubitemid 39097095)
41. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994;43:505-509
42. Pileggi A, Ricordi C, Alessiani M, Inverardi L. Factors influencing islet of Langerhans graft function and monitoring. Clin Chim Acta 2001;310:3-16 (Pubitemid 32727310)
43. Davalli AM, Ogawa Y, Ricordi C, Scharp DW, Bonner-Weir S, Weir GC. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 1995;59:817-820
44. Coddington DA, Yang H, Rowden G, Colp P, Issekutz TB, Wright JR Jr. Islet allograft rejection in rats: a time course study characterizing adhesion molecule expression, MHC expression, and infiltrate immunophenotypes. Cell Transplant 1998;7:285-297 (Pubitemid 28280857)
45. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729
46. Ogasawara K, Hamerman JA, Hsin H, et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003;18:41-51 (Pubitemid 36120686)